Search research articles
Contact Us
Filters
Showing results (451-460 of 696) with videos related to
Page
of 70
Sort By:
FEBS Letters
|
December 12, 1997
Design of mu selective opioid dipeptide antagonists
A Capasso, P Amodeo, G Balboni, et al.
Seminars in Hematology
|
July 1, 1992
Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin
J Krischer, G Elfenbein, R Babington, et al.
Minerva Medica
|
February 20, 2004
Thyroglobulin: current aspects of its role in autoimmune thyroid disease and thyroid cancer
O E Okosieme, A B Parkes, L D K E Premawardhana, et al.
International Journal of Peptide and Protein Research
|
February 1, 1995
Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity
G Balboni, S Salvadori, F D'Angeli, et al.
Journal of Medicinal Chemistry
|
August 1, 2009
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore
Gianfranco Balboni, Claudio Trapella, Yusuke Sasaki, et al.
Cancer
|
March 1, 1971
Malignant potential of a cell line isolated from the peripheral blood in infectious mononucleosis
R A Adams, E E Hellerstein, L Pothier, et al.
Journal of Medicinal Chemistry
|
December 10, 1999
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism
S Salvadori, R Guerrini, G Balboni, et al.
Peptides
|
January 1, 1993
Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity
L H Lazarus, S Salvadori, M Attila, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 2, 2014
Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs)
Jonathan P Bestwick, Rhys John, Aldo Maina, et al.
Cancer Research
|
May 1, 1978
Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia
H Lazarus, E F Barell, A Krishan, et al.
Page
of 70
Search research articles
Search
Showing results (451-460 of 696) with videos related to
Sort By:
Page
of 70
FEBS Letters
|
December 12, 1997
Design of mu selective opioid dipeptide antagonists
A Capasso, P Amodeo, G Balboni, et al.
Seminars in Hematology
|
July 1, 1992
Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin
J Krischer, G Elfenbein, R Babington, et al.
Minerva Medica
|
February 20, 2004
Thyroglobulin: current aspects of its role in autoimmune thyroid disease and thyroid cancer
O E Okosieme, A B Parkes, L D K E Premawardhana, et al.
International Journal of Peptide and Protein Research
|
February 1, 1995
Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity
G Balboni, S Salvadori, F D'Angeli, et al.
Journal of Medicinal Chemistry
|
August 1, 2009
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore
Gianfranco Balboni, Claudio Trapella, Yusuke Sasaki, et al.
Cancer
|
March 1, 1971
Malignant potential of a cell line isolated from the peripheral blood in infectious mononucleosis
R A Adams, E E Hellerstein, L Pothier, et al.
Journal of Medicinal Chemistry
|
December 10, 1999
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism
S Salvadori, R Guerrini, G Balboni, et al.
Peptides
|
January 1, 1993
Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity
L H Lazarus, S Salvadori, M Attila, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 2, 2014
Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs)
Jonathan P Bestwick, Rhys John, Aldo Maina, et al.
Cancer Research
|
May 1, 1978
Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia
H Lazarus, E F Barell, A Krishan, et al.
Page
of 70